Unleash the potential of AI in drug design and digital health


SoftMining is a company founded in 2019 that uses AI for the design of new drugs and new materials with unprecedented efficiency. The methods, models and algorithms developed during more than 15 years of university scientific research have been integrated into a complete development platform.

The results achieved are remarkable: 2 new antibiotics have been designed, 4 patents applications have been filed, a new biodegradable material for PVC replacement has been discovered, two molecules with antitumor activity have entered into clinical trials (Phase II), and a new technique of chemical synthesis on solid support has been developed.

Our science

Drugs and materials discovery pipeline

APPs pipeline


Stefano Piotto

Bioinformatician and entrepreneur. He got a Master in Chemistry at Univ. Rome, and PhD in Materials Science at ETH Zurich. He is Ass. Prof. at Univ. Salerno, and he is the CEO and cofounder of a successful startup SmartVase Srl, active on biomaterials.

Lucia Sessa

in silico Drug Design
Lucia received a Ph.D. in Pharmaceutical Science in 2014 from the Univ. of Salerno. She worked at the Swiss Federal Institute of Technology (ETH). She is an expert in drug design and she is co-founder of SmartVase Srl.

Luigi Di Biasi

Code development
Luigi is a computer scientist skilled in code development for biology problems. He developed methods to treat with large dataset, and with distributed computing. He studied in Univ. Salerno, and he is also cofounder of Arrowsoft srl.

Digital Magics


Latest news